John Steven

705 total citations
23 papers, 547 citations indexed

About

John Steven is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, John Steven has authored 23 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Immunology. Recurrent topics in John Steven's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Enzyme Production and Characterization (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). John Steven is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Enzyme Production and Characterization (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). John Steven collaborates with scholars based in United Kingdom, United States and Belgium. John Steven's co-authors include Caroline J. Barelle, A.J. Porter, Marina Kovaleva, Laura T. Ferguson, D. J. Ballance, A. R. Goodey, Mischa Müller, Kenneth Saunders, Graham Belfield and Leslie Evans and has published in prestigious journals such as Nature Biotechnology, Cancer Research and Chemical Communications.

In The Last Decade

John Steven

23 papers receiving 521 citations

Peers

Countries citing papers authored by John Steven

Since Specialization

Citations

This map shows the geographic impact of John Steven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Steven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Steven more than expected).

Fields of papers citing papers by John Steven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Steven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Steven. The network helps show where John Steven may publish in the future.

Co-authorship network of co-authors of John Steven

This figure shows the co-authorship network connecting the top 25 collaborators of John Steven. A scholar is included among the top collaborators of John Steven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Steven. John Steven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Functionalization of polymeric nanoparticles with targeting VNAR ligands using vinyl sulfone conjugation 2023 ·Journal of Materials Chemistry B ·(unknown), (unknown), (unknown), (unknown), John Steven, P. P. A. Smyth, A.J. Porter, Caroline J. Barelle, Efrosyni Themistou, Christopher J. Scott	4
2	Anti-DLL4 VNAR targeted nanoparticles for targeting of both tumour and tumour associated vasculature 2020 ·Nanoscale ·(unknown), Peter Smyth, Laura T. Ferguson, John Steven, Michelle K. Greene, Cristina Branco, (unknown), A.J. Porter, Caroline J. Barelle, Christopher J. Scott	18
3	An Anti-hTNF-α Variable New Antigen Receptor Format Demonstrates Superior in vivo Preclinical Efficacy to Humira® in a Transgenic Mouse Autoimmune Polyarthritis Disease Model 2019 ·Frontiers in Immunology ·(unknown), John Steven, A.J. Porter, Caroline J. Barelle	18
4	Uveitis Therapy With Shark Variable Novel Antigen Receptor Domains Targeting Tumor Necrosis Factor Alpha or Inducible T-Cell Costimulatory Ligand 2019 ·Translational Vision Science & Technology ·Kathryn L. Pepple, Leslie Wilson, Russell N. Van Gelder, Marina Kovaleva, (unknown), John Steven, Caroline J. Barelle, A.J. Porter	6
5	Abstract 222: Novel protein drug conjugates targeting ROR1 through the development and exploitation of a drug discovery platform based on small, engineered VNAR domains 2019 ·Cancer Research ·Graham Cotton, (unknown), (unknown), Stacey J. Bell, (unknown), Mark Wappett, Caroline J. Barelle, Marina Kovaleva, John Steven, A.J. Porter, Estelle McLean, (unknown), (unknown), Aaron Cranston, Tim J. Harrison	3
6	Next-generation flexible formats of VNAR domains expand the drug platform's utility and developability 2018 ·Biochemical Society Transactions ·(unknown), (unknown), Laura T. Ferguson, Marina Kovaleva, John Steven, A.J. Porter, Caroline J. Barelle	34
7	Novel, Anti-hTNF-α Variable New Antigen Receptor Formats with Enhanced Neutralizing Potency and Multifunctionality, Generated for Therapeutic Development 2017 ·Frontiers in Immunology ·(unknown), John Steven, Marina Kovaleva, Laura T. Ferguson, (unknown), A.J. Porter, Caroline J. Barelle	27
8	In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties to Facilitate Clinical Development 2017 ·Frontiers in Immunology ·John Steven, Mischa Müller, Miguel F. Carvalho, (unknown), Marina Kovaleva, Gerard G. Donohoe, Thomas C. Baddeley, (unknown), Kenneth Saunders, A.J. Porter, Caroline J. Barelle	36
9	Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis 2017 ·Frontiers in Immunology ·Marina Kovaleva, Katherine Johnson, John Steven, Caroline J. Barelle, A.J. Porter	37
10	Shark variable new antigen receptor biologics – a novel technology platform for therapeutic drug development 2014 ·Expert Opinion on Biological Therapy ·Marina Kovaleva, Laura T. Ferguson, John Steven, A.J. Porter, Caroline J. Barelle	70
11	Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain 2012 ·mAbs ·Mischa Müller, Kenneth Saunders, Christopher Grace, (unknown), Nicole Piche‐Nicholas, John Steven, (unknown), Leeying Wu, (unknown), Yulia Vugmeyster, Timothy P. Hickling, Lioudmila Tchistiakova, Stéphane Olland, Davinder Gill, Allan Jensen, Caroline J. Barelle	73
12	Characterization of the immunoglobulin repertoire of the spiny dogfish (Squalus acanthias) 2011 ·Developmental & Comparative Immunology ·(unknown), Kathryn Crouch, Wei Cao, Mischa Müller, Leeying Wu, John Steven, Michael Lee, (unknown), Martin F. Flajnik, Heather H. Shih, Caroline J. Barelle, Janet Paulsen, Davinder Gill, Helen Dooley	34
13	A humanised murine monoclonal antibody with broad serogroup specificity protects mice from challenge with Venezuelan equine encephalitis virus 2011 ·Antiviral Research ·Sarah A. Goodchild, Lyn M. O’Brien, John Steven, (unknown), (unknown), Christopher H. Logue, Riccardo V. D’Elia, R.J. Phillpotts, Stuart D. Perkins	19
14	Why YPEL3 represents a novel tumor suppressor 2010 ·Frontiers in bioscience ·John Steven	10
15	Isolation of High Molecular Weight DNA Suitable for the Construction of Genomic Libraries 2003 ·Humana Press eBooks ·John Steven, Douglas GJ McKechnie, Alexander Graham	1
16	A hybrid protein of urokinase growth‐factor domain and plasminogen‐activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor 1992 ·European Journal of Biochemistry ·D. J. Ballance, (unknown), Ian Cottingham, John Steven, (unknown), (unknown), A. R. Goodey, Michael Courtney	7
17	Secretion of single-chain urokinase-type plasminogen activator from insect cells 1991 ·Gene ·Linda A. King, Kulwinder Kaur, (unknown), Alison M. Lawrie, John Steven, Jill E. Ogden	4
18	Saccharomyces Cerevisiae Strains that Overexpress Heterologous Proteins 1991 ·Nature Biotechnology ·Darrell Sleep, Graham Belfield, D. J. Ballance, John Steven, Stephen D. Jones, Leslie Evans, (unknown), A. R. Goodey	60
19	Purification and characterisation of plasminogen activator inhibitor 2 produced in Saccharomyces cerevisiae 1991 ·European Journal of Biochemistry ·John Steven, Ian Cottingham, (unknown), (unknown), A. R. Goodey, Michael Courtney, D. J. Ballance	18
20	Vitellogenin genes and their products in closely and distantly related species of Xenopus 1985 ·Comparative Biochemistry and Physiology Part B Comparative Biochemistry ·Betty S. Baker, John Steven, Jamshed R. Tata	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact